Back

Coronary CT assessment of left atrial remodeling in hypertrophic cardiomyopathy reveals selective lateral wall thickening

13 April 2026 (10:30 - 11:15)
Organised by: Logo
Congress Presentation Part of: Arrhythmias and remodeling Cellular Mechanisms of Arrhythmias EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Magdalena Klis

King's College London, London (United Kingdom of Great Britain & Northern Ireland)

6 More presentations in this session

Presentation thumbnail
Remodeling and reverse-remodeling of left atrium and appendage after catheter ablation for atrial fibrillation
Doctor T. Kawaji (Kyoto, JP)
Abstract Slides Video
Presentation thumbnail
Early reverse remodeling of the mitral valve apparatus following atrial fibrillation ablation: insights from a prospective echocardiographic study
Doctor S. Sanli (Istanbul, TR)
Abstract Slides Video
Presentation thumbnail
Left atrial Soluble ST2 and BNP response after pulmonary vein isolation as a predictor of atrial fibrillation recurrence
Associate Professor M. Somuncu (Aydin, TR)
Abstract Slides Video
Presentation thumbnail
Left-atrial function in relation to BMI in patients undergoing catheter ablation for atrial fibrillation
Mr C. Eitel (Kuenzell, DE)
Abstract Slides Video
Presentation thumbnail
P-wave signal-averaged ECG as a marker of left atrial electrical and structural remodeling in patients with atrial fibrillation
Doctor A. Karanikola (Athens, GR)
Abstract Slides Video

Access the full session

Session thumbnail
Arrhythmias and remodeling

The Event

Event poster

EHRA 2026

13 April 2026 10:30 CET
You may be interested in
thumbnail
Congress Presentation
Atrial substrate and electrogram characterization in patients with atrial fibrillation and hypertrophic cardiomyopathy
thumbnail
Congress Presentation
Left atrial remodeling in hypertrophic cardiomyopathy: morphological and transcriptional insights
thumbnail
Congress Presentation
Long-term trajectories of left atrial remodeling and their prognostic impact in hypertrophic cardiomyopathy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources